Samonis, G., Maraki, S., Karageorgopoulos, D., Vouloumanou, E., & Falagas, M. (2012). Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. European Journal of Clinical Microbiology & Infectious Diseases, 31(5), 695. https://doi.org/10.1007/s10096-011-1360-5
Chicago Style (17th ed.) CitationSamonis, G., S. Maraki, D. Karageorgopoulos, E. Vouloumanou, and M. Falagas. "Synergy of Fosfomycin with Carbapenems, Colistin, Netilmicin, and Tigecycline Against Multidrug-resistant Klebsiella Pneumoniae, Escherichia Coli, and Pseudomonas Aeruginosa Clinical Isolates." European Journal of Clinical Microbiology & Infectious Diseases 31, no. 5 (2012): 695. https://doi.org/10.1007/s10096-011-1360-5.
MLA (9th ed.) CitationSamonis, G., et al. "Synergy of Fosfomycin with Carbapenems, Colistin, Netilmicin, and Tigecycline Against Multidrug-resistant Klebsiella Pneumoniae, Escherichia Coli, and Pseudomonas Aeruginosa Clinical Isolates." European Journal of Clinical Microbiology & Infectious Diseases, vol. 31, no. 5, 2012, p. 695, https://doi.org/10.1007/s10096-011-1360-5.